Additional file 4: of Priming with Toll-like receptor 3 agonist or interferon-gamma enhances the therapeutic effects of human mesenchymal stem cells in a murine model of atopic dermatitis

Table S2. Upstream regulators of key cytokines that are expressed in interferon-gamma (IFN-γ)-primed Wharton’s jelly-derived mesenchymal stem cells (WJ-MSCs). (XLS 49 kb)